Toxicity of CSF in motor neurone disease: a potential route to neuroprotection.
Shaw
Pamela J
PJ
D000818:Animals; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D002556:Cerebrospinal Fluid Proteins / Q000378:metabolism / Q000633:toxicity*; D006801:Humans; D017628:Microglia / Q000187:drug effects / Q000378:metabolism; D008911:Minocycline / Q000627:therapeutic use*; D016472:Motor Neuron Disease / Q000134:cerebrospinal fluid* / Q000188:drug therapy* / Q000503:physiopathology; D009046:Motor Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009498:Neurotoxins / Q000378:metabolism / Q000633:toxicity*; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D013116:Spinal Cord / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology
D002556:Cerebrospinal Fluid Proteins; D018696:Neuroprotective Agents; D009498:Neurotoxins; D008911:Minocycline